Determining and forecasting end of life for an implantable medical device having a rechargeable battery

• US 10,806,930 B2
• Filed: 01/24/2018
• Issued: 10/20/2020
• Est. Priority Date: 01/16/2014
• Status: Active Grant

• Current Assignee: Boston Scientific Neuromodulation Corporation (Boston Scientific Corporation)
• Original Assignee: Boston Scientific Neuromodulation Corporation (Boston Scientific Corporation)
• Inventors: Marnfeldt, Goran N., Carbunaru, Rafael, Parramon, Jordi
• Primary Examiner(s): Evanisko, George R
• Application Number:
  US15/879,095
• Publication Number:
  US 20180152025A1
• Time in Patent Office: 1,000 Days
• CPC Class Codes: A61N 1/36128 Control systems
• CPC Class Codes: A61N 1/3708 for power depletion
• CPC Class Codes: A61N 1/378 Electrical supply
• CPC Class Codes: G01R 31/3648 comprising digital calculation means, e.g. for performing an algorithm
• CPC Class Codes: G01R 31/392 Determining battery ageing or deterioration, e.g. state of health
• CPC Class Codes: H02J 2310/23 The load being a medical device, a medical implant, or a life supporting device
• CPC Class Codes: H02J 7/00 Circuit arrangements for charging or depolarising batteries or for supplying loads from batteries
• CPC Class Codes: H02J 7/00034 Charger exchanging data with an electronic device, i.e. telephone, whose internal battery is under charge
• CPC Class Codes: H02J 7/0048 Detection of remaining charge capacity or state of charge [SOC]
• CPC Class Codes: H02J 7/0049 Detection of fully charged condition
• CPC Class Codes: H02J 7/005 Detection of state of health [SOH]

Abstract

An algorithm programmed into the control circuitry of a rechargeable-battery Implantable Medical Device (IMD) is disclosed that can quantitatively forecast and determine the timing of an early replacement indicator (tEOLi) and an IMD End of Life (tEOL). These forecasts and determinations of tEOLi and tEOL occur in accordance with one or more parameters having an effect on rechargeable battery capacity, such as number of charging cycles, charging current, discharge depth, load current, and battery calendar age. The algorithm consults such parameters as stored over the history of the operation of the IMD in a parameter log, and in conjunction with a battery capacity database reflective of the effect of these parameters on battery capacity, determines and forecasts tEOLi and tEOL. Such forecasted or determined values may also be used by a shutdown algorithm to suspend therapeutic operation of the IMD.

Claims

1. A system, comprising:

an implantable medical device comprising a rechargeable battery and control circuitry, wherein the control circuitry is configured to estimate a capacity of the rechargeable battery at different points in time during operation of the implantable medical device and configured to determine at least one first parameter during each previous charging session of the rechargeable battery, wherein each of the capacities are estimated using the determined at least one parameter, wherein the control circuitry is further configured to determine a forecasted end of life of the implantable medical device using the estimated capacities; and

an external device configured to receive and display the forecasted end of life of the implantable medical device.

2. The system of claim 1, further comprising an external charger configured to wirelessly charge the rechargeable battery of the implantable medical device.

3. The system of claim 1, wherein the external device comprises a patient external controller.

4. The system of claim 1, wherein the external device comprises a clinician'"'"'s programmer.

5. The system of claim 1, wherein the implantable medical device further comprises telemetry circuitry configured to telemeter the forecasted end of life to the external device.

6. The system of claim 5, wherein the telemetry circuitry is configured to telemeter the forecasted end of life upon receipt of a command from the external device, or when the external device initiates a communication session with the implantable medical device.

7. The system of claim 1, wherein the control circuitry is further configured to suspend therapeutic operation of the implantable medical device when the forecasted end of life has been reached.

8. The system of claim 1, wherein the control circuitry is configured to store a shutdown time at which therapeutic operation of the implantable medical device is normally suspended.

9. The system of claim 8, wherein if the stored shutdown time has been reached and is earlier than the forecasted end of life, the control circuitry is further configured to extend therapeutic operation of the implantable medical device beyond the shutdown time.

10. The system of claim 8, wherein if the stored forecasted end of life has been reached and is earlier than the shutdown time, the control circuitry is further configured to suspend therapeutic operation of the implantable medical device.

11. The system of claim 1, wherein the forecasted end of life is determined as a time at which the rechargeable battery is expected to reach a capacity threshold.

12. The system of claim 1, wherein the control circuitry is further configured to determine a forecasted early replacement indicator for the implantable medical device that precedes the forecasted end of life, and wherein the external device is configured to receive and display the forecasted early replacement indicator for the implantable medical device.

13. The system of claim 12, wherein the control circuitry is configured to determine the forecasted early replacement indicator using the estimates of the capacity of the rechargeable battery at the different points in time during operation of the implantable medical device.

14. The system of claim 13, wherein the implantable medical device further comprises telemetry circuitry configured to telemeter the forecasted early replacement indicator to the external device.

15. The system of claim 12, wherein the forecasted early replacement indicator is determined as a first time at which the rechargeable battery is expected to reach a first capacity threshold.

16. The system of claim 15, wherein the forecasted end of life is determined as a second time later than the first time at which the rechargeable battery is expected to reach a second capacity threshold.

17. The system of claim 12, wherein the early replacement indicator is forecasted using the forecasted end of life.

18. The system of claim 17, wherein the forecasted early replacement indicator comprises a set time before the forecasted end of life.

19. The system of claim 1, wherein the at least one first parameter comprises one or more of a number of the previous charging sessions of the rechargeable battery, a voltage of the rechargeable battery at the start of at least one previous charging session, a voltage of the rechargeable battery at the end of at least one previous charging session, a duration of at least one previous charging session, a charge provided to the rechargeable battery during at least one previous charging session, a discharge depth comprising a difference between a voltage of the rechargeable battery at the start and finish of at least one previous charging sessions, and a battery charging current provided to the rechargeable battery during at least one previous charging sessions.

20. The system of claim 1, wherein the capacities are further estimated using at least one second parameter determined during previous use of the implantable medical device to provide therapy between the previous charging sessions, and/or an age of the rechargeable battery.